Results 191 to 200 of about 638,721 (253)
Biomass Native Structure Into Functional Carbon‐Based Catalysts for Fenton‐Like Reactions
Advanced Functional Materials, EarlyView.This study indicates that eight biomasses with 2D flaky and 1D acicular structures influence surface O types, morphology, defects, N doping, sp2 C, and Co nanoparticles loading in three series of carbon, N‐doped carbon, and cobalt/graphitic carbon. This work identifies how these structural factors impact catalytic pathways, enhancing selective electron
Wenjie Tian +7 more
wiley +1 more source
Electroactive Metal–Organic Frameworks for Electrocatalysis
Advanced Functional Materials, EarlyView.Electrocatalysis is crucial in sustainable energy conversion as it enables efficient chemical transformations. The review discusses how metal–organic frameworks can revolutionize this field by offering tailorable structures and active site tunability, enabling efficient and selective electrocatalytic processes.
Irena Senkovska +7 more
wiley +1 more source
Multiple drug resistance in Salmonellae.
Indian journal of medical sciences, 1984 M L, Mago +3 more
openaire +1 more source
[Multiple-drug-resistant tubercle bacilli].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997 openaire +1 more source
Multiple Drug Resistant Gonococcal lnfection.
Indian journal of dermatology, venereology and leprologyK, Pavithran, C, Gangadharan
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medicinal Research Reviews, 1999
Multiple drug resistance to antibacterial agents, antifungals, antivirals, antiprotozoals, and antitumor agents has risen spectacularly in the last decade or so and presently threatens eventually to put an end to successful chemotherapy in all of the above fields.
L A, Mitscher +3 more
openaire +2 more sources
Multiple drug resistance to antibacterial agents, antifungals, antivirals, antiprotozoals, and antitumor agents has risen spectacularly in the last decade or so and presently threatens eventually to put an end to successful chemotherapy in all of the above fields.
L A, Mitscher +3 more
openaire +2 more sources
MULTIPLE DRUG–RESISTANT TUBERCULOSIS
Infectious Disease Clinics of North America, 1998The national and international emergence of drug-resistant M. tuberculosis has complicated both the programmatic control of the tuberculosis epidemic and the clinical management of individual cases. In the United States, the problem of MDR tuberculosis is regionalized and likely stems from multifactorial causes, including the concurrent HIV epidemic ...
W Z, Bradford, C L, Daley
openaire +2 more sources
MULTIPLE PATHWAY DRUG-RESISTANCE (REVIEW)
International Journal of Oncology, 1993During the past few years it has become apparent that multiple mechanisms of resistance are playing a role in the clinical manifestations of drug resistance. In different organs and tumors, various components of the resistance phenotype are expressed to varying degrees.
J, Mattern, M, Volm
openaire +2 more sources
Drug resistance in multiple myeloma
Cancer Treatment Reviews, 2018Multiple myeloma (MM, plasma cell myeloma) is a malignant hematologic disease characterized by the clonal proliferation of malignant plasma cells. The treatment of MM has changed dramatically in recent years, with the introduction of new drugs into therapeutic strategies, both in the front line setting and in relapsed refractory disease.
Pawel, Robak +3 more
openaire +2 more sources
Multiple drug resistance inAerobacter aerogenes
Antonie van Leeuwenhoek, 1967Multiple drug resistance resulting from continued growth in various drugs in turn followed by serial subculture in the simultaneous presence of all the drugs has been studied. In this way strains ofA. aerogenes resistant, in considerable measure, to 3, 4 and 5 drugs have been obtained.
P G, Bolton, A C, Dean, P J, Rodgers
openaire +2 more sources